Trailblazer R21: New & Early-Stage Investigators — engineering/physical sciences + biomedical (clinical trial optional)
NIH Trailblazer R21 supports New and Early Stage Investigators with $400,000 direct costs over three years to pursue high‑risk, high‑reward projects that integrate engineering, physical, or quantitative sciences with biomedical research. Clinical trials are optional but limited to early-stage/first‑in‑human or feasibility studies; extensive preliminary data are discouraged to encourage explora…
The rapid evolution and vitality of the biomedical sciences benefit from the contributions and creativity of investigators in the early stages of their careers, and a continuous infusion of new ideas, techniques, and perspectives from other fields. This Trailblazer Award is an opportunity for Ne…
Funding Source
Awards & funding
Eligibility
- Foreign/Non-domestic entities: Non-domestic (non-U.S.) Entities (Foreign Organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are NOT eligible to apply. However, foreign components (as defined in the NIH Grants Policy Statement) are allowed wit…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers